These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 17785848)

  • 1. Ligation of B and T lymphocyte attenuator prevents the genesis of experimental cerebral malaria.
    Lepenies B; Pfeffer K; Hurchla MA; Murphy TL; Murphy KM; Oetzel J; Fleischer B; Jacobs T
    J Immunol; 2007 Sep; 179(6):4093-100. PubMed ID: 17785848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B and T lymphocyte attenuator restricts the protective immune response against experimental malaria.
    Adler G; Steeg C; Pfeffer K; Murphy TL; Murphy KM; Langhorne J; Jacobs T
    J Immunol; 2011 Nov; 187(10):5310-9. PubMed ID: 21998455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-γ-producing CD4+ T cells promote experimental cerebral malaria by modulating CD8+ T cell accumulation within the brain.
    Villegas-Mendez A; Greig R; Shaw TN; de Souza JB; Gwyer Findlay E; Stumhofer JS; Hafalla JC; Blount DG; Hunter CA; Riley EM; Couper KN
    J Immunol; 2012 Jul; 189(2):968-79. PubMed ID: 22723523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unexpected role of B and T lymphocyte attenuator in sustaining cell survival during chronic allostimulation.
    Hurchla MA; Sedy JR; Murphy KM
    J Immunol; 2007 May; 178(10):6073-82. PubMed ID: 17475832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of CD4+ Effector Responses by Naturally Occurring CD4+ CD25+ Foxp3+ Regulatory T Cells Contributes to Experimental Cerebral Malaria.
    Blanc AL; Keswani T; Gorgette O; Bandeira A; Malissen B; Cazenave PA; Pied S
    Infect Immun; 2016 Jan; 84(1):329-38. PubMed ID: 26553468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of protein on BTLAlow cells and in vivo antibody-mediated down-modulation of BTLA on lymphoid and myeloid cells of C57BL/6 and BALB/c BTLA allelic variants.
    del Rio ML; Kaye J; Rodriguez-Barbosa JI
    Immunobiology; 2010 Jul; 215(7):570-8. PubMed ID: 19837478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria.
    Campanella GS; Tager AM; El Khoury JK; Thomas SY; Abrazinski TA; Manice LA; Colvin RA; Luster AD
    Proc Natl Acad Sci U S A; 2008 Mar; 105(12):4814-9. PubMed ID: 18347328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical role of IL-33 receptor ST2 in experimental cerebral malaria development.
    Palomo J; Reverchon F; Piotet J; Besnard AG; Couturier-Maillard A; Maillet I; Tefit M; Erard F; Mazier D; Ryffel B; Quesniaux VF
    Eur J Immunol; 2015 May; 45(5):1354-65. PubMed ID: 25682948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malaria-specific and nonspecific activation of CD8+ T cells during blood stage of Plasmodium berghei infection.
    Miyakoda M; Kimura D; Yuda M; Chinzei Y; Shibata Y; Honma K; Yui K
    J Immunol; 2008 Jul; 181(2):1420-8. PubMed ID: 18606696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T follicular helper expansion and humoral-mediated rejection are independent of the HVEM/BTLA pathway.
    Rodriguez-Barbosa JI; Fernandez-Renedo C; Moral AMB; Bühler L; Del Rio ML
    Cell Mol Immunol; 2017 Jun; 14(6):497-510. PubMed ID: 26924526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator.
    Gonzalez LC; Loyet KM; Calemine-Fenaux J; Chauhan V; Wranik B; Ouyang W; Eaton DL
    Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1116-21. PubMed ID: 15647361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perforin-dependent brain-infiltrating cytotoxic CD8+ T lymphocytes mediate experimental cerebral malaria pathogenesis.
    Nitcheu J; Bonduelle O; Combadiere C; Tefit M; Seilhean D; Mazier D; Combadiere B
    J Immunol; 2003 Feb; 170(4):2221-8. PubMed ID: 12574396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type I interferons contribute to experimental cerebral malaria development in response to sporozoite or blood-stage Plasmodium berghei ANKA.
    Palomo J; Fauconnier M; Coquard L; Gilles M; Meme S; Szeremeta F; Fick L; Franetich JF; Jacobs M; Togbe D; Beloeil JC; Mazier D; Ryffel B; Quesniaux VF
    Eur J Immunol; 2013 Oct; 43(10):2683-95. PubMed ID: 23780878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NK cells and conventional dendritic cells engage in reciprocal activation for the induction of inflammatory responses during Plasmodium berghei ANKA infection.
    Ryg-Cornejo V; Nie CQ; Bernard NJ; Lundie RJ; Evans KJ; Crabb BS; Schofield L; Hansen DS
    Immunobiology; 2013 Feb; 218(2):263-71. PubMed ID: 22704523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B and T lymphocyte attenuator mediates inhibition of tumor-reactive CD8+ T cells in patients after allogeneic stem cell transplantation.
    Hobo W; Norde WJ; Schaap N; Fredrix H; Maas F; Schellens K; Falkenburg JH; Korman AJ; Olive D; van der Voort R; Dolstra H
    J Immunol; 2012 Jul; 189(1):39-49. PubMed ID: 22634623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic effects of B and T lymphocyte attenuator extracellular domain and heat shock protein 70 antigen peptide on cervical cancer in mouse model].
    Han LF; Qiu WM; Hu C; Wang L; Yao HX; Xiong SY; Meng M; Fang Y; Ma D
    Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):603-8. PubMed ID: 21029617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutting edge: selective blockade of LIGHT-lymphotoxin beta receptor signaling protects mice from experimental cerebral malaria caused by Plasmodium berghei ANKA.
    Randall LM; Amante FH; Zhou Y; Stanley AC; Haque A; Rivera F; Pfeffer K; Scheu S; Hill GR; Tamada K; Engwerda CR
    J Immunol; 2008 Dec; 181(11):7458-62. PubMed ID: 19017933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Novel CD4
    Fernandez-Ruiz D; Lau LS; Ghazanfari N; Jones CM; Ng WY; Davey GM; Berthold D; Holz L; Kato Y; Enders MH; Bayarsaikhan G; Hendriks SH; Lansink LIM; Engel JA; Soon MSF; James KR; Cozijnsen A; Mollard V; Uboldi AD; Tonkin CJ; de Koning-Ward TF; Gilson PR; Kaisho T; Haque A; Crabb BS; Carbone FR; McFadden GI; Heath WR
    J Immunol; 2017 Dec; 199(12):4165-4179. PubMed ID: 29084838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transcription factor T-bet regulates parasitemia and promotes pathogenesis during Plasmodium berghei ANKA murine malaria.
    Oakley MS; Sahu BR; Lotspeich-Cole L; Solanki NR; Majam V; Pham PT; Banerjee R; Kozakai Y; Derrick SC; Kumar S; Morris SL
    J Immunol; 2013 Nov; 191(9):4699-708. PubMed ID: 24078698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine malaria is exacerbated by CTLA-4 blockade.
    Jacobs T; Graefe SE; Niknafs S; Gaworski I; Fleischer B
    J Immunol; 2002 Sep; 169(5):2323-9. PubMed ID: 12193697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.